December 22, 2024 12:39 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Mohali building collapse: Death toll rises to 2, many feared trapped for 17 hours | 4-year-old killed after speeding car driven by a teen hits him in Mumbai | PM Modi attends opening ceremony of Arabian Gulf Cup in Kuwait | Jaipur gas tanker crash: Toll touches 14, 30 critical | Arrest warrant against former cricketer Robin Uthappa over 'PF fraud' | PM Modi emplanes for a visit to Kuwait | German Christmas market car attack leaves 2 dead, Saudi Arabian doctor arrested | India, France come together to build world's largest museum in Delhi's Raisina Hill | Canada, US presented no evidence of Indians' involvement in purported criminal acts: Centre informs Parliament amid 'serious allegations' | Delhi Police Crime Branch to investigate FIR against Rahul Gandhi over Parliament tussle

Diabetes-inducing blood vessel damage could be prevented by a growth factor, study finds

Jan 06, 2019, at 09:11 pm

London, Jan 6 (IBNS): Scientists have identified a growth factor found in the kidneys that could minimise the diabetes-inducing effects of blood vessel damage.

Four clinical trials suggest doctors focus on heart disease, not just glucose, says study

Jul 09, 2017, at 01:03 am

New York, July 8 (IBNS): Heart disease is a leading cause of death worldwide and exacerbated by type 2 diabetes, yet diabetes treatment regimens tend to focus primarily on blood sugar maintenance. This common approach to type 2 diabetes management can leave patients at risk for heart attack and stroke. But results from four recent randomized clinical trials suggest that using medications that offer glucose control while reducing the risk for cardiovascular disease could improve patient outcomes.

Research elucidates hormone ghrelin’s role in blood glucose regulation, a finding with promising implications for diabetes treatment

May 10, 2017, at 03:38 am

Dallas, May 9 (IBNS): UT Southwestern research investigating the blood glucose-regulatory actions of the hormone ghrelin may have implications for development of new treatments for diabetes.